Diacylglycerol acyltransferase inhibitors
US7317125B2 · kind B2 · utility
8Cited by
1References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2006 |
| Grant date | Jan 8, 2008 |
| Priority date | — |
| Expiry date | Jan 31, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.